Use of FINDRISC in the Screening of Diabetes in Asymptomatic Patients

  • Rosa Dantas Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Teresa Azevedo Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Márcia Alves Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Margarida Balsa Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Isabel Albuquerque Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Marília Ferreira Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Carla Pedrosa Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Fernanda Gomes Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Catarina Fonseca Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal
  • Joana Guimarães Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal

Abstract

Introduction: To evaluate the potential of FINDRISC (Finnish Diabetes Risk Score) as a tool for screening and detection of cases of prediabetes and diabetes in a sample of Portuguese asymptomatic patients. 


Methods: An observational, analytical and transversal study conducted in the Centro Hospitalar do Baixo Vouga, Unidade de Aveiro. Population of the area of influence of CHBV. Exclusion criteria: people with diabetes, pregnant, bedridden, hospitalized or institutionalized, with motor deficit, mental disease incapacitating or difficulties of comprehension of the Portuguese language. Personal or online completion of the survey “Finnish Diabetes Risk Score” to assess the risk of developing diabetes mellitus at 10 years followed by the determination of HbA1C in the DCA2000© in patients with moderate to high risk. The cases with HbA1c ≥ 5.7%, performed laboratory tests (oral glucose tolerance test (OGTT) with 75 g of glucose and HbA1c laboratory determination in venous blood). Statistical analysis was made through the Statistical Package for the Social Sciences (SPSS) version 18®. 


Results: Of the 82 participants attended, 77.4% were female, and 51.2% presented more than 55 years. The HbA1c was determined in 40 users (48.8%) who presented moderate to very high risk. The mean obtained in these was 5.7% (4.8-6.4%). Sixteen participants held OGTT and determination of HbA1C in the venous blood. Two participants (2.4%), male, with more than 64 years had diabetes, and were directed to specialized appointment. Nine participants (11%) presented prediabetes and were oriented to the attending physician. Both diabetics were high risk and about 22.2% of those who had had only moderate risk presented prediabetes. 


Conclusion: In November, in Portugal, several screening actions for diabetes are developed, based often on capillary blood glucose research. However, this may not be the most appropriate method. In this study, we demonstrate that the survey “Finnish diabetes risk score”, alone or conjugated with laboratorial evaluation, may be an important tool in the screening of diabetes, allowing the selection of patients at higher risk that require a specific approach. 

Published
Jul 6, 2017
How to Cite
DANTAS, Rosa et al. Use of FINDRISC in the Screening of Diabetes in Asymptomatic Patients. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, [S.l.], v. 12, n. 1, p. 45-51, july 2017. ISSN 2183-9514. Available at: <http://www.spedmjournal.com/index.php/spedm/article/view/80>. Date accessed: 20 sep. 2017.
Section
Original Articles